Shanghai RAAS Blood Products Co., Ltd. engages in the manufacture and sale of blood products in China. It offers human albumin, human intravenous immunoglobulin, human coagulation factor VIII, human prothrombin complex concentrate, human fibrinogen, human thrombin and human fibrin sealant, human immunoglobulin, hepatitis B immunoglobulin, tetanus immunoglobulin, and rabies immunoglobulin products. It also provides testing services for blood products, vaccines, diagnostic reagents, and testing equipment. The company also exports its products to Southeast Asia and Latin America. Shanghai RAAS Blood Products Co., Ltd. was founded in 1988 and is based in Shanghai, China.
• Shanghai RAAS Blood Products announced a semi annually dividend of ¥0.04 per ordinary share which will be made payable on 2024-09-30. Ex dividend date: 2024-09-30 • Shanghai RAAS Blood Products annual dividend for 2024 was ¥0.07 • Shanghai RAAS Blood Products annual dividend for 2023 was ¥0.03 • Shanghai RAAS Blood Products's trailing twelve-month (TTM) dividend yield is 0.9% • Shanghai RAAS Blood Products's payout ratio for the trailing twelve months (TTM) is 23.16%
Shanghai RAAS Blood Products current trailing twelve-month (TTM) dividend yield is 0.9%. Interested in purchasing Shanghai RAAS Blood Products stock? Use our calculator to estimate your expected dividend yield:
Shanghai RAAS Blood Products Financial Ratios
P/E ratio27.70
PEG ratio-7.86
P/B ratio1.63
ROE6.00%
Payout ratio23.16%
Current ratio4.21
Quick ratio2.41
Cash Ratio1.72
Shanghai RAAS Blood Products Dividend FAQ
How much is the next Shanghai RAAS Blood Products dividend?
Shanghai RAAS Blood Products's board of directors will review the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the next Shanghai RAAS Blood Products dividend. The next Shanghai RAAS Blood Products dividend will be released in June.
When is Shanghai RAAS Blood Products dividend paid?
Shanghai RAAS Blood Products pays dividends on a semi annually basis. The specific dates may vary each year but are generally around June. However, please note that the exact timing and amount can vary, and companies may also decide to change their dividend policy based on their financial health and other considerations.
What dividend does Shanghai RAAS Blood Products pay?
The specific amount of Shanghai RAAS Blood Products dividend can vary from quarter to quarter and year to year, based on a variety of factors including the company's financial performance, the global economic situation, and the decisions of its board of directors. In the above table you can find Shanghai RAAS Blood Products's dividend history.
Does Shanghai RAAS Blood Products stock pay dividends?
Yes, Shanghai RAAS Blood Products does pay dividends to its shareholders. However, the specific amount and frequency of these dividends can vary based on a variety of factors, including the company's financial performance, the global economic situation, and the decisions of its board of directors. In the above table you can find Shanghai RAAS Blood Products's dividend history.
How much dividend does Shanghai RAAS Blood Products pay?
Shanghai RAAS Blood Products paid ¥0.067 in 2024, ¥0.03 in 2023, ¥0.028 in 2022, ¥0.025 in 2021, and ¥0.01 in 2020.
How often does Shanghai RAAS Blood Products pay dividends?
Shanghai RAAS Blood Products typically pays dividends on a semi annually basis. This means that dividends are usually distributed 2 times a year. The specific payout dates may vary each year but generally fall around June.
What is Shanghai RAAS Blood Products's dividend yield?
The current dividend yield for Shanghai RAAS Blood Products is 0.9%. The dividend yield is calculated by dividing the annual dividend payment by the price of the stock. Both of these numbers can fluctuate daily due to changes in the stock price and any updates to the dividend payment. Use the dividend calculator on this page to calculate Shanghai RAAS Blood Products's exact dividend yield.
When does Shanghai RAAS Blood Products go ex dividend?
Shanghai RAAS Blood Products's ex-dividend date for the latest dividend was on 2024-09-30. Shanghai RAAS Blood Products typically goes ex-dividend a few weeks before the payment date. The specific dates can vary each year and for each dividend payment.
When is the next Shanghai RAAS Blood Products dividend paid?
Shanghai RAAS Blood Products pays dividends on a semi annually basis, typically around June, but the exact dates can vary each year.
Will Shanghai RAAS Blood Products increase its dividend?
Decisions about dividend payments are made by the company's board of directors and are based on a variety of factors. To understand whether Shanghai RAAS Blood Products will increase its dividend, it's beneficial to look at the company's earnings, financial health, future business prospects, and the overall economic environment.
How much is Shanghai RAAS Blood Products dividend per share?
Shanghai RAAS Blood Products paid ¥0.067 per share in 2024 and ¥0.03 per share in 2023. The amount of dividend per share that Shanghai RAAS Blood Products pays can vary each quarter based on a range of factors including the company's earnings, financial health, and decisions made by its board of directors.
Is Shanghai RAAS Blood Products a dividend aristocrat?
No, the term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Shanghai RAAS Blood Products a dividend king?
No, a "Dividend King" is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Shanghai RAAS Blood Products a dividend stock?
Yes, Shanghai RAAS Blood Products is considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
Is Shanghai RAAS Blood Products a good dividend stock?
Whether Shanghai RAAS Blood Products is a good dividend stock depends on several factors and can vary depending on individual investment goals, risk tolerance, and the overall market conditions. Shanghai RAAS Blood Products has a history of paying regular dividends, which can make it attractive to income-focused investors.
Other factors to consider when evaluating Shanghai RAAS Blood Products as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Does Shanghai RAAS Blood Products pay dividends monthly?
Shanghai RAAS Blood Products typically pays dividends on a semi annually basis.
Does Shanghai RAAS Blood Products pay dividends quarterly?
Shanghai RAAS Blood Products currently pays dividends on a semi annually basis.
Has Shanghai RAAS Blood Products ever paid a dividend?
Yes, Shanghai RAAS Blood Products has a history of paying dividends to its shareholders. Shanghai RAAS Blood Products is known for its dividend payments, which have made it an attractive investment for income-focused investors.
How to buy Shanghai RAAS Blood Products dividend stocks?
To buy Shanghai RAAS Blood Products you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees, account minimums, and the availability of dividend reinvestment programs (DRIPs) if you wish to reinvest your dividends automatically.
Place an order: Use the brokerage's trading platform to place an order to buy Shanghai RAAS Blood Products stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
When does Shanghai RAAS Blood Products pay dividends 2024?
Shanghai RAAS Blood Products pays dividends on a semi annually basis. 2024 dividend payments are in 2024-09-30. However, please note that the exact timing and amount can vary, and companies may also decide to change their dividend policy based on their financial health and other considerations.
Will Shanghai RAAS Blood Products increase its dividend in 2024?
Decisions regarding Shanghai RAAS Blood Products dividend increases are typically made by a company's board of directors based on various factors, including financial performance, cash flow, investment needs, and market conditions. For an up-to-date Shanghai RAAS Blood Products dividend overview you can look into the above table of dividend history.
How Shanghai RAAS Blood Products dividend works?
The Shanghai RAAS Blood Products dividend works by distributing a portion of the company's profits to its shareholders on a per-share basis. Here's a general overview of how Shanghai RAAS Blood Products's dividend process works:
1. Determination of Dividend: Shanghai RAAS Blood Products's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Shanghai RAAS Blood Products publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Shanghai RAAS Blood Products distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Shanghai RAAS Blood Products are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
How are Shanghai RAAS Blood Products dividends paid?
Shanghai RAAS Blood Products dividends are typically paid in cash directly to eligible shareholders. The payment process involves the following steps:
1. Record Date: Shanghai RAAS Blood Products sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Shanghai RAAS Blood Products distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Shanghai RAAS Blood Products declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
How many times does Shanghai RAAS Blood Products pay dividends?
Shanghai RAAS Blood Products typically pays dividends on a semi annually basis. The specific payment dates can vary each year and are usually announced when the company releases its financial results for each quarter.
What months does Shanghai RAAS Blood Products pay dividends?
The general pattern is that Shanghai RAAS Blood Products pays dividends around June. However, the exact payment dates can vary each year and are typically announced when the company releases its financial results for each quarter.
Is Shanghai RAAS Blood Products dividend safe?
The safety of Shanghai RAAS Blood Products's dividend is subject to various factors and cannot be determined with certainty. It is influenced by the company's financial performance, cash flow, and the overall economic and industry conditions.
To assess the safety of Shanghai RAAS Blood Products's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Shanghai RAAS Blood Products's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.